"In 2010, the Government proposed moving towards a broader value-based system for assessing and pricing branded drugs. Such an approach aims to ensure that the price the NHS pays for a medicine better reflects its benefits. This briefing outlines recent proposals to change the current assessment methods."
Value based assessment of drugs
Parliamentary Office of Science & Technology
Houses of Parliament
Postnote, number 487, January 2015
Read more here.
No comments:
Post a Comment